Trademark Search in Canada

AMPTIFI

View On IC.GC.CA

CANCELLED

Last Applicant/ Owned by

OTSUKA PHARMACEUTICAL CO. LTD.

2-9 Kanda-Tsukasamachi, Chiyoda-kuTokyo 101-8535

Serial Number

2131130 filed on 9^th Jul 2021

Registration Number

TMA1155564 registered on 7^th Dec 2022

Registration expiry Date

9^th Jul 2031

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

K1P5Y6

AMPTIFI

Trademark usage description

anti-psychotics; central nervous system stimulants; central nervous system depressants; pharmaceutical preparations for the treatment of schizophrenia Read More

Classification Information

Class [005]
Anti-psychotics; central nervous system stimulants; central nervous system depressants; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of bipolar disorder; pharmaceutical preparations for the treatment of irritability associated with autistic disorder.

Classification kind code

Mark Details

Serial Number

2131130

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 222 on 12^th Sept 2022	Opposition Start Date Notice Sent
Submitted for opposition 27 on 16^th Aug 2022	Approval Notice Sent
Submitted for opposition 26 on 16^th Aug 2022	Approved
Submitted for opposition 22 on 10^th Aug 2022	Search Recorded
Submitted for opposition 256 on 4^th Jul 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 2^th Sept 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 1^st Sept 2021	Created
Submitted for opposition 31 on 1^st Sept 2021	Formalized
Submitted for opposition 228 on 9^th Jul 2021	International Registration
Submitted for opposition 30 on 9^th Jul 2021	Filed